Acquired MET exon 14 alteration drives secondary resistance to epidermal growth factor receptor tyrosine kinase inhibitor in EGFR-mutated lung cancer

Ken Suzawa, Michael Offin, Adam J. Schoenfeld, Andrew J. Plodkowski, Igor Odintsov, Daniel Lu, William W. Lockwood, Maria E. Arcila, Charles M. Rudin, Alexander Drilon, Helena A. Yu, Gregory J. Riely, Romel Somwar, Marc Ladanyi

Research output: Contribution to journalArticlepeer-review

38 Citations (Scopus)
Original languageEnglish
JournalJCO Precision Oncology
Publication statusPublished - 2019
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this